CYP2C19

Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: A Case Report

Del Toro-Pagán NM, Matos A, Bardolia C, Michaud V, Turgeon J, Amin NS Published 1/20/2022 Abstract Background Response to antidepressant therapy is highly variable among individuals. Pharmacogenomic (PGx) testing presents an opportunity to guide drug selection while optimizing therapy [...]

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4